Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × INDUSTRY × Ointments × Clear all

Phase

Status

Completed 4 Withdrawn 1 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 1

Interventions

pembrolizumab 218 Carboplatin 157 Injections 114 Paclitaxel 109 Cisplatin 108 Bevacizumab 102 Gemcitabine 101 Pemetrexed 75 Docetaxel 74 Cyclophosphamide 53 Capecitabine 52 Fluorouracil 50 Oxaliplatin 47 Fulvestrant 45 Cetuximab 45 Nivolumab 44 130-nm albumin-bound paclitaxel 43 Dexamethasone 40 atezolizumab 39 Rituximab 38 Leucovorin 37 fludarabine 35 venetoclax 34 toripalimab 33 Lenalidomide 32 Drug Therapy 32 enzalutamide 30 durvalumab 30 Prednisone 28 Azacitidine 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡